Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06196840
Status:
RECRUITING
Last Update Posted:
2024-01-09
First Post:
2023-12-25
Brief Title:
Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration nAMD VENUS
Sponsor:
Innostellar Biotherapeutics CoLtd
Organization:
Innostellar Biotherapeutics CoLtd
Organization Data
Organization:
Innostellar Biotherapeutics CoLtd
Class:
INDUSTRY
Study ID:
INNOSTELLAR-LX102A01-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Innostellar Biotherapeutics CoLtd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None